{"id":476243,"date":"2023-10-30T19:10:13","date_gmt":"2023-10-31T02:10:13","guid":{"rendered":"https:\/\/nai500.com\/blog\/2023\/10\/%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e6%8a%95%e8%b5%84-%e5%af%92%e5%86%ac-%e5%9f%ba%e5%9b%a0%e7%96%97%e6%b3%95-%e9%87%8d%e5%a4%a7%e7%aa%81%e7%a0%b4\/"},"modified":"2023-10-30T19:10:37","modified_gmt":"2023-10-31T02:10:37","slug":"%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e6%8a%95%e8%b3%87-%e5%af%92%e5%86%ac-%e5%9f%ba%e5%9b%a0%e7%99%82%e6%b3%95-%e9%87%8d%e5%a4%a7%e7%aa%81%e7%a0%b4","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2023\/10\/%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e6%8a%95%e8%b3%87-%e5%af%92%e5%86%ac-%e5%9f%ba%e5%9b%a0%e7%99%82%e6%b3%95-%e9%87%8d%e5%a4%a7%e7%aa%81%e7%a0%b4\/","title":{"rendered":"\u751f\u7269\u79d1\u6280\u6295\u8cc7\u7684\u201c\u5bd2\u51ac\u201d\u4e4b\u4e0b\uff0c\u57fa\u56e0\u7642\u6cd5\u6216\u5373\u5c07\u8fce\u4f86\u91cd\u5927\u7a81\u7834"},"content":{"rendered":"<p>1990\u5e749\u670814\u65e5\u767c\u751f\u4e86\u91ab\u5b78\u53f2\u4e0a\u4e00\u6b21\u91cd\u5927\u4e8b\u4ef6\uff1a4\u6b72\u5973\u5b69Ashanti DeSilva\u6210\u70ba\u5168\u7403\u7b2c\u4e00\u4f4d\u63a5\u53d7\u57fa\u56e0\u7642\u6cd5\u7684\u4eba\uff0c\u4e26\u4e14\u904e\u4e0a\u4e86\u6b63\u5e38\u7684\u751f\u6d3b\u3002\u4f46\u5728\u6b64\u4e4b\u5f8c\uff0c\u56e0\u70ba\u904b\u8f09\u5de5\u5177\u7684\u5b89\u5168\u6027\u64d4\u6182\uff0c\u57fa\u56e0\u7642\u6cd5\u884c\u696d\u9072\u9072\u6c92\u6709\u91cd\u5927\u7a81\u7834\u3002<\/p>\n<p>\u4e0d\u904e\u57282010\u5e74\u4e4b\u5f8c\uff0c\u96a8\u8457\u65b0\u7684\u57fa\u56e0\u4fee\u98fe\u6280\u8853\u7684\u51fa\u73fe\u4ee5\u53ca\u904b\u8f09\u7cfb\u7d71\u5b89\u5168\u6027\u7684\u63d0\u5347\uff0c\u56f0\u64fe\u57fa\u56e0\u7de8\u8f2f\u6cbb\u7642\u9818\u57df\u7684\u9019\u500b\u6839\u672c\u6027\u96e3\u984c\u624d\u7d42\u65bc\u6709\u89e3\u3002<\/p>\n<h2>\u4e00\u500b\u95dc\u9375\u7684\u8f49\u6298\u9ede<\/h2>\n<p>\u76ee\u524d\u57fa\u56e0\u7642\u6cd5\u6700\u6709\u524d\u666f\u7684\u9069\u61c9\u75c7\u4e4b\u4e00\u662f\u942e\u72c0\u7d30\u80de\u75c5\uff08SCD\uff09\u3002\u942e\u72c0\u7d30\u80de\u75c5\u76ee\u524d\u9084\u6c92\u6709\u6cbb\u7652\u65b9\u6cd5\uff0c\u4f46<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CRSP\">CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09<\/a>\u548c\u798f\u6cf0\u88fd\u85e5Vertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09\u806f\u5408\u958b\u767c\u7684\u57fa\u56e0\u7642\u6cd5exa-cel\u6216\u6539\u8b8a\u9019\u4e00\u5207\u3002<\/p>\n<p>Exa-cel\u4f7f\u7528\u57fa\u56e0\u7de8\u8f2f\u5de5\u5177CRISPR\/Cas9\u5c0d\u60a3\u8005\u7684\u5e79\u7d30\u80de\u9032\u884c\u4fee\u98fe\uff0c\u63d0\u9ad8\u80ce\u5152\u8840\u7d05\u86cb\u767d\u7684\u751f\u6210\u6c34\u5e73\u3002\u7136\u5f8c\u5c07\u7de8\u8f2f\u5f8c\u7684\u7d30\u80de\u56de\u8f38\u5230\u60a3\u8005\u9ad4\u5167\uff0c\u751f\u6210\u5065\u5eb7\u7684\u7d05\u7d30\u80de\u3002\u5728\u81e8\u5e8a\u7814\u7a76\u7576\u4e2d\uff0cExa-cel\u5df2\u7d93\u5c55\u73fe\u51fa\u51fa\u8272\u7684\u6709\u6548\u6027\u7d50\u679c\uff0c\u4e26\u6709\u671b\u5f88\u5feb\u6210\u70ba\u7b2c\u4e00\u500b\u7372\u6279\u7684\u942e\u72c0\u7d30\u80de\u75c5\u57fa\u56e0\u7642\u6cd5\u3002<\/p>\n<p>\u672c\u5468\uff0cexa-cel\u5c07\u8fce\u4f86\u4e00\u500b\u95dc\u9375\u8003\u9a57\uff1a\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7ba1\u5c40\uff08FDA\uff09\u7684\u8aee\u8a62\u59d4\u54e1\u6703\u6703\u8b70\u3002\u8a72\u59d4\u54e1\u6703\u5c07\u5be9\u8a55exa-cel\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u6578\u64da\uff0c\u4e26\u5c31\u662f\u5426\u6279\u51c6\u8a72\u57fa\u56e0\u7642\u6cd5\u5411FDA\u63d0\u51fa\u5efa\u8b70\u3002\u4e00\u822c\u60c5\u6cc1\u4e0b\uff0cFDA\u90fd\u6703\u807d\u5f9e\u8a72\u59d4\u54e1\u6703\u7684\u5efa\u8b70\uff0c\u56e0\u6b64\u8a72\u6703\u8b70\u7d50\u679c\u5c0d\u65bc\u57fa\u56e0\u7642\u6cd5\u4e43\u81f3\u6574\u500b\u751f\u7269\u79d1\u6280\u884c\u696d\u90fd\u5c07\u7522\u751f\u91cd\u5927\u7684\u5f71\u97ff\u3002<\/p>\n<p>\u4f46\u662f\uff0c\u57fa\u56e0\u7642\u6cd5\u9818\u57df\u7684\u91cd\u5927\u7a81\u7834\u4e26\u4e0d\u5fc5\u7136\u610f\u5473\u8457\u57fa\u56e0\u7de8\u8f2f\u80a1\u7968\u6295\u8cc7\u8005\u7684\u201c\u5927\u8c50\u6536\u201d\u3002<\/p>\n<h2>\u751f\u7269\u79d1\u6280\u80a1\u7968\u7684\u201c\u6295\u8cc7\u5bd2\u51ac\u201d<\/h2>\n<p>\u5728\u5927\u7d0410\u5e74\u5de6\u53f3\u7684\u6642\u9593\u88e1\uff0cexa-cel\u5f9e\u4e00\u500b\u6982\u5ff5\u6162\u6162\u8d70\u5411\u53ef\u80fd\u7684\u4e0a\u5e02\u7522\u54c1\uff0c\u4f46CRISPR Therapeutics\u7684\u5e02\u503c\u537b\u5728\u904e\u53bb3\u5e74\u7e2e\u6c34\u5927\u7d04120\u5104\u7f8e\u5143\u3002\u6838\u5fc3\u539f\u56e0\u5728\u65bc\uff0c\u5e02\u5834\u76f8\u4fe1\u5373\u4f7fexa-cel 12\u6708\u7372\u6279\uff0c\u4e5f\u5f88\u96e3\u53d6\u5f97\u5546\u696d\u4e0a\u7684\u5de8\u5927\u6210\u529f\u3002<\/p>\n<p>\u7a76\u5176\u539f\u56e0\uff0c\u5f88\u591a\u5176\u4ed6\u57fa\u56e0\u7642\u6cd5\uff0c\u5176\u4e2d\u5305\u62ecBluebird bio Inc\uff08NASDAQ:BLUE\uff09\u7684lovo-cel\uff0cBeam Therapeutics Inc.\uff08NASDAQ:BEAM\uff09\u7684\u583f\u57fa\u7de8\u8f2f\u5019\u9078\u7642\u6cd5\uff0c\u4ee5\u53caEditas Medicine Inc\uff08NASDAQ:EDIT\uff09\u7684CRISPR\/Cas9\u7642\u6cd5\u90fd\u5728\u9032\u884c\u942e\u72c0\u7d30\u80de\u75c5\u7684\u958b\u767c\uff0c\u6709\u4e9b\u7642\u6cd5\u7684\u5b89\u5168\u6027\u751a\u81f3\u512a\u65bcexa-cel\u3002<\/p>\n<p>\u5373\u4f7f\u4e0d\u8003\u616e\u7af6\u722d\u98a8\u96aa\uff0c\u5373\u4f7fexa-cel\u6700\u7d42\u7372\u6279\uff0cCRISPR Therapeutics\u7684\u80a1\u50f9\u4e5f\u6975\u6709\u53ef\u80fd\u4e0d\u6f32\u53cd\u8dcc\u3002\u539f\u56e0\u4e5f\u5f88\u7c21\u55ae\uff0c\u73fe\u5728\u662f\u751f\u7269\u79d1\u6280\u80a1\u7968\u6295\u8cc7\u7684\u201c\u5bd2\u51ac\u201d\u3002\u5728\u9762\u5c0d\u751f\u7269\u79d1\u6280\u80a1\u7968\u6642\uff0c\u73fe\u5728\u7684\u5e02\u5834\u5df2\u7d93\u8b8a\u5f97\u6975\u5ea6\u4e0d\u7406\u6027\uff0c\u5177\u9ad4\u8868\u73fe\u70ba\u6578\u5341\u5bb6\u516c\u53f8\u7684\u5e02\u503c\u903c\u8fd1\u5b83\u5011\u7684\u73fe\u91d1\u6c34\u5e73\u3002\u800c\u4e14\uff0c2023\u5e74\u5927\u91cf\u516c\u53f8\u5728\u767c\u4f48\u7a4d\u6975\u7684\u81e8\u5e8a\u6216\u5be9\u6279\u6d88\u606f\u4e4b\u5f8c\uff0c\u80a1\u7968\u537b\u906d\u5927\u898f\u6a21\u62cb\u552e\u3002<\/p>\n<h2>\u9577\u7dda\u601d\u7dad<\/h2>\n<p>\u5728\u9762\u5c0d\u9019\u500b\u4f4e\u8ff7\u7684\u751f\u7269\u79d1\u6280\u80a1\u7968\u5e02\u5834\u6642\uff0c\u8070\u660e\u7684\u6295\u8cc7\u8005\u61c9\u7576\u805a\u7126\u9577\u671f\u800c\u975e\u77ed\u671f\u3002CRISPR Therapeutics\u64c1\u6709\u5927\u91cf\u7684\u5c16\u7aef\u7642\u6cd5\u5728\u7814\u9805\u76ee\uff0c\u8ddf\u798f\u6cf0\u88fd\u85e5\u4fdd\u6301\u5bc6\u5207\u7684\u5408\u4f5c\u95dc\u4fc2\uff0c\u800c\u4e14\u6709\u80fd\u529b\u901a\u904e\u7814\u767c\u62ff\u51fa\u5019\u9078\u7522\u54c1\u3002\u56e0\u6b64\uff0c\u53ea\u8981\u6295\u8cc7\u8005\u6709\u8010\u5fc3\uff0c\u9019\u53ea\u57fa\u56e0\u7de8\u8f2f\u5148\u92d2\u80a1\u7968\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u500b\u5b89\u9032Amgen\uff08NASDAQ:AMGN\uff09\u6216\u518d\u751f\u5143\u88fd\u85e5Regeneron Pharmaceuticals\uff08NASDAQ:REGN\uff09\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1990\u5e749\u670814\u65e5\u767c\u751f\u4e86\u91ab\u5b78\u53f2\u4e0a\u4e00\u6b21\u91cd\u5927\u4e8b\u4ef6\uff1a4\u6b72\u5973\u5b69Ashanti DeSilva\u6210\u70ba\u5168\u7403\u7b2c\u4e00\u4f4d\u63a5\u53d7\u57fa\u56e0\u7642 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":476240,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,927,2233,564],"class_list":["post-476243","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-927","tag-2233","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/476243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=476243"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/476243\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/476240"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=476243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=476243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=476243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}